In June 2006, the Food and Drug Administration approved a vaccine against HPV for use in women. The currently available vaccine (several pharmaceutical companies are developing a version) targets HPV strains 6 and 11, which cause 90 percent of genital warts — as well as the major cervical cancer causing strains, 16 and 18. Given as a set of three shots over six months, the vaccine will protect against only those four strains, and will not cure existing infections.
If this does prove to be effective , then maybe a vaccine for other strains is not an impossibility in the near future.